-
94% reduction in risk! After the approval of weight loss pills, Lilly, the "world's drug king", welcomes the benefits again: new experimental drugs significantly reduce the risk of heart disease and last for nearly a year
Less than a week after the new weight loss drug Zepbound was approved by the US Food and Drug Administration (FDA), Lilly, the world's largest pharmaceutical company by market value (NYSE: LLC, stock ...